Andrew Gill

Title: Innovations by Andrew Gill in Hematocrit-Corrected Analyte Concentrations

Introduction

Andrew Gill is an accomplished inventor based in Alloa, GB. He has made significant contributions to the field of medical diagnostics, particularly in the area of hematocrit-corrected analyte concentrations. With a total of two patents to his name, his work has the potential to enhance the accuracy of blood analysis.

Latest Patents

Andrew Gill's latest patents focus on methods for determining hematocrit-corrected analyte concentrations. The first patent describes a method that involves providing a test strip with a reference electrode and a working electrode coated with a reagent layer. The process includes applying a fluid sample to the test strip, measuring a test current, and calculating a hematocrit-corrected concentration of analyte based on the steady state current value. The second patent outlines a similar method specifically for determining hematocrit-corrected glucose concentrations, utilizing a test strip with microelectrodes and a reagent layer. Both patents emphasize the importance of accurate measurements in medical diagnostics.

Career Highlights

Andrew Gill is currently associated with Lifescan Scotland Limited, where he continues to innovate in the field of medical technology. His work has been instrumental in developing methods that improve the reliability of blood tests, which are crucial for patient care.

Collaborations

Andrew has collaborated with notable colleagues such as Stephen Patrick Blythe and Marco Fabio Cardosi. Their combined expertise has contributed to the advancement of diagnostic methods in the medical field.

Conclusion

Andrew Gill's innovative work in hematocrit-corrected analyte concentrations showcases his commitment to improving medical diagnostics. His patents reflect a deep understanding of the complexities involved in accurate blood analysis, which can significantly impact patient outcomes.